Advanced Oxygen Technologies Inc (AOXY) — SEC Filings
Advanced Oxygen Technologies Inc (AOXY) — 8 SEC filings. Latest: 10-Q (Nov 10, 2025). Includes 6 10-Q, 2 10-K.
View Advanced Oxygen Technologies Inc on SEC EDGAR
Overview
Advanced Oxygen Technologies Inc (AOXY) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 10, 2025: ADVANCED OXYGEN TECHNOLOGIES INC (AOXY) reported a net loss of $3,445 for the three months ended September 30, 2025, an improvement from the $4,475 net loss in the same period of 2024. Total revenues increased to $11,781 from $10,885 year-over-year, primarily from rent revenues generated by its Dani
Sentiment Summary
Across 8 filings, the sentiment breakdown is: 1 bullish, 3 bearish, 4 neutral. The dominant filing sentiment for Advanced Oxygen Technologies Inc is neutral.
Filing Type Overview
Advanced Oxygen Technologies Inc (AOXY) has filed 6 10-Q, 2 10-K with the SEC between Jan 2024 to Nov 2025.
Filings by Year
Recent SEC Filings (8)
| Date | Form | Description | Risk |
|---|---|---|---|
| Nov 10, 2025 | 10-Q | AOXY Narrows Q3 Loss to $3,445 Amidst Flat Revenue Growth | high |
| Sep 11, 2025 | 10-K | AOXY's Revenue Hinges on Single Lease, Distribution Arm Stalls | high |
| May 1, 2025 | 10-Q | Advanced Oxygen Technologies Reports Net Income | medium |
| Jan 17, 2025 | 10-Q | Advanced Oxygen Technologies Q2 2025 Update | low |
| Nov 4, 2024 | 10-Q | Advanced Oxygen Technologies Q1 Loss Widens | high |
| Sep 17, 2024 | 10-K | Advanced Oxygen Technologies Inc. Files 2024 10-K | low |
| May 13, 2024 | 10-Q | Advanced Oxygen Technologies Inc. Files 10-Q for Period Ending March 31, 2024 | medium |
| Jan 24, 2024 | 10-Q | ADVANCED OXYGEN TECHNOLOGIES INC Files 10-Q for Period Ending 2023-12-31 |
Risk Profile
Risk Assessment: Of AOXY's 7 recent filings, 3 were flagged as high-risk, 2 as medium-risk, and 2 as low-risk. The overall risk profile suggests elevated risk that warrants close monitoring.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $11,781 |
| Net Income | -$3,445 |
| EPS | N/A |
| Debt-to-Equity | N/A |
| Cash Position | $45,546 |
| Operating Margin | -108.2% |
| Total Assets | N/A |
| Total Debt | N/A |
Key Executives
- Harry Edelson
Industry Context
Advanced Oxygen Technologies Inc. operates in a niche segment focused on real estate leasing through its Danish subsidiary. The broader commercial real estate market is influenced by economic conditions, interest rates, and tenant demand. Companies in this sector often rely on long-term leases to ensure stable revenue streams.
Top Tags
10-Q (4) · financials (3) · Micro-cap (1) · Net Loss (1) · Real Estate Lease (1) · Liquidity Risk (1) · Denmark Operations (1) · Limited Revenue (1) · OTC Pink (1) · Microcap (1)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net Loss | $3,445 | Improved from $4,475 in Q3 2024 |
| Total Revenues | $11,781 | Increased from $10,885 in Q3 2024 |
| Cash at End of Period | $45,546 | Decreased from $57,225 at June 30, 2025 |
| Accumulated Deficit | $20,756,078 | As of September 30, 2025, indicating historical losses |
| Lease Expiration Year | 2026 | Primary revenue source lease with Circle K Denmark A/S |
| Total Operating Expenses | $12,754 | Decreased from $13,059 in Q3 2024 |
| Advances from a related party | $40,953 | Decreased from $55,974 at June 30, 2025 |
| Common Shares Outstanding | 3,292,945 | Consistent across both periods |
| Aggregate market value of Common Stock held by non-affiliates | $88,628 | As of December 31, 2024, indicating a microcap status. |
| Issued and outstanding shares of Common Stock | 3,292,945 | As of September 11, 2025. |
| Lease expiration year for ANV's sole customer | 2026 | Represents a critical future revenue risk for the company. |
| Revenues for Sharx subsidiary | 0 | For years ended June 30, 2025, and 2024, highlighting operational failure. |
| Total employees | 2 | As of June 30, 2025, indicating minimal operational scale. |
| Cash received from patent sale | $335,000 | In 1995, demonstrating a past business model shift. |
| Total Assets | $60.0B | As of March 31, 2025 |
Frequently Asked Questions
What are the latest SEC filings for Advanced Oxygen Technologies Inc (AOXY)?
Advanced Oxygen Technologies Inc has 8 recent SEC filings from Jan 2024 to Nov 2025, including 6 10-Q, 2 10-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of AOXY filings?
Across 8 filings, the sentiment breakdown is: 1 bullish, 3 bearish, 4 neutral. The dominant sentiment is neutral.
Where can I find Advanced Oxygen Technologies Inc SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Advanced Oxygen Technologies Inc (AOXY) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Advanced Oxygen Technologies Inc?
Key financial highlights from Advanced Oxygen Technologies Inc's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for AOXY?
The investment thesis for AOXY includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Advanced Oxygen Technologies Inc?
Key executives identified across Advanced Oxygen Technologies Inc's filings include Harry Edelson.
What are the main risk factors for Advanced Oxygen Technologies Inc stock?
Of AOXY's 7 assessed filings, 3 were flagged high-risk, 2 medium-risk, and 2 low-risk.
What are recent predictions and forward guidance from Advanced Oxygen Technologies Inc?
Forward guidance and predictions for Advanced Oxygen Technologies Inc are extracted from SEC filings as they are enriched.